2
Clinical Trials associated with Varicella attenuated live vaccine(Chengdu Biotec) / Enrolling by invitationPhase 4 An Open Clinical Trial to Evaluate the Immunity Persistence of Live Attenuated Varicella Vaccine At 5 and 8 Years After Primary Immunization with Live Attenuated Varicella Vaccine
This an open phase Ⅳ clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunity persistence of live attenuated varicella vaccine at 5 and 8 years after primary immunization with live attenuated varicella vaccine.
开放性临床试验,用于评价水痘减毒活疫苗初次单剂接种的免疫持久性以及加强免疫的安全性和免疫原性
[Translation] An open clinical trial to evaluate the durability of immunity after a single initial dose of live attenuated varicella vaccine and the safety and immunogenicity of booster immunization
评价科兴(大连)疫苗技术有限公司生产的水痘减毒活疫苗初次单剂接种后不同时间的免疫持久性以及加强免疫的安全性和免疫原性。
[Translation] To evaluate the persistence of immunity at different times after the initial single dose of the live attenuated varicella vaccine produced by Sinovac (Dalian) Vaccine Technology Co., Ltd., as well as the safety and immunogenicity of booster immunization.
100 Clinical Results associated with Varicella attenuated live vaccine(Chengdu Biotec)
100 Translational Medicine associated with Varicella attenuated live vaccine(Chengdu Biotec)
100 Patents (Medical) associated with Varicella attenuated live vaccine(Chengdu Biotec)
100 Deals associated with Varicella attenuated live vaccine(Chengdu Biotec)